Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Asset disposition
Quarterly results
|
|
INOVIO PHARMACEUTICALS, INC. (INO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2023 |
4
| Sumner Michael John (Chief Medical Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 85,878 restricted stock units
@ $0 |
|
| 05/17/2023 |
4
| Humeau Laurent (Chief Scientific Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 171,756 restricted stock units
@ $0 |
|
| 05/17/2023 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 171,756 restricted stock units
@ $0 |
|
| 05/17/2023 |
4
| Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 638,800 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| Zoth Lota S. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 19,000 restricted stock units
@ $0
Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| YARNO WENDY L (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 19,000 restricted stock units
@ $0
Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| Weiner David B. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 19,000 restricted stock units
@ $0
Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| Shepard Jay (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 19,000 restricted stock units
@ $0
Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| BENITO SIMON X (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 19,000 restricted stock units
@ $0
Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| Miller Ann Calby (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 19,000 restricted stock units
@ $0
Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| DANSEY ROGER D (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 12,000 restricted stock units
@ $0
Granted 35,000 options
@ $0.77, valued at
$27k
Granted 26,000 restricted stock units
@ $0
Exercised 19,000 restricted stock units
@ $0 |
|
| 05/12/2023 |
4
| Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 28,704 shares
@ $0.81, valued at
$23.3k
Exercised 66,000 restricted stock units
@ $0 |
|
| 03/13/2023 |
4
| Weiner David B. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Sold 5,833 shares
@ $1.15, valued at
$6.7k
Exercised 11,666 restricted stock units
@ $0 |
|
| 03/13/2023 |
4
| Humeau Laurent (Chief Scientific Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 20,658 shares
@ $1.13, valued at
$23.3k
Exercised 59,737 restricted stock units
@ $0 |
|
| 03/13/2023 |
4
| Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 25,980 shares
@ $1.13, valued at
$29.4k
Exercised 59,737 restricted stock units
@ $0 |
|
| 03/13/2023 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 31,410 shares
@ $1.13, valued at
$35.5k
Exercised 59,737 restricted stock units
@ $0 |
|
| 02/28/2023 |
4
| Shea Jacqueline Elizabeth (CEO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 9,788 shares
@ $1.28, valued at
$12.5k
Paid exercise price by delivering 32,485 shares
@ $1.28, valued at
$41.6k
Exercised 22,544 restricted stock units
@ $0
Exercised 70,234 restricted stock units
@ $0
Granted 836,800 options
@ $1.24, valued at
$1M
|
|
| 02/28/2023 |
4
| KIES PETER (CFO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 12,928 shares
@ $1.28, valued at
$16.5k
Paid exercise price by delivering 28,195 shares
@ $1.28, valued at
$36.1k
Exercised 22,544 restricted stock units
@ $0
Exercised 47,967 restricted stock units
@ $0
Granted 225,000 options
@ $1.24, valued at
$279k
|
|
| 02/28/2023 |
4
| Weiner David B. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Sold 11,668 shares
@ $1.28, valued at
$14.9k
Exercised 11,667 restricted stock units
@ $0
Granted 60,000 options
@ $1.24, valued at
$74.4k
Granted 35,000 restricted stock units
@ $0 |
|
| 02/28/2023 |
4
| Sumner Michael John (Chief Medical Officer) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Granted 112,500 options
@ $1.24, valued at
$139.5k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2022 |
4
| Weiner David B. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 11,875 shares
@ $2.16, valued at
$25.7k
Sold 11,875 shares
@ $2.66, valued at
$31.6k
Exercised 11,875 options
@ $0 |
|
| 07/20/2022 |
4
| BENITO SIMON X (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 2,000 shares
@ $2.2, valued at
$4.4k
Sold 2,000 shares
@ $2.25, valued at
$4.5k
Exercised 2,000 options
@ $0 |
|
| 07/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Weiner David B. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Sold 9,000 shares
@ $1.95, valued at
$17.6k
Exercised 18,000 restricted stock units
@ $0
Granted 19,000 restricted stock units
@ $0
Granted 28,000 options
@ $1.89, valued at
$52.9k
|
|
| 05/17/2022 |
4
| Shepard Jay (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 18,000 restricted stock units
@ $0
Granted 19,000 restricted stock units
@ $0
Granted 28,000 options
@ $1.89, valued at
$52.9k
|
|
| 05/17/2022 |
4
| Zoth Lota S. (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Sold 3,600 shares
@ $1.98, valued at
$7.1k
Exercised 18,000 restricted stock units
@ $0
Granted 19,000 restricted stock units
@ $0
Granted 28,000 options
@ $1.89, valued at
$52.9k
|
|
| 05/17/2022 |
4
| BENITO SIMON X (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 18,000 restricted stock units
@ $0
Granted 19,000 restricted stock units
@ $0
Granted 28,000 options
@ $1.89, valued at
$52.9k
|
|
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| YARNO WENDY L (Director) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Exercised 18,000 restricted stock units
@ $0
Granted 19,000 restricted stock units
@ $0
Granted 28,000 options
@ $1.89, valued at
$52.9k
|
|
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2022 |
4
| Shea Jacqueline Elizabeth (COO) has filed a Form 4 on INOVIO PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 7,247 shares
@ $3.63, valued at
$26.3k
Exercised 16,666 restricted stock units
@ $0 |
|
|
|
|